Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

The Lancet , Volume 378 (9807): -1921 – Dec 12, 2011

Loading next page...
 
/lp/pubmed/comparative-effectiveness-of-axitinib-versus-sorafenib-in-advanced-3BmJ63zePT

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2011 Elsevier Ltd. All rights reserved.
ISSN
0140-6736
eISSN
1474-547X
DOI
10.1016/S0140-6736(11)61613-9
pmid
22056247

Abstract

Journal

The LancetPubmed

Published: Dec 12, 2011

There are no references for this article.